The first QuiremScout cases successfully performed

The first QuiremScout cases have been successfully performed by clinical teams in Dresden and Pisa last week. We congratulate the clinical teams, and everyone involved! QuiremScout is the first and only CE-marked SIRT work-up product that consists of the same particle as the therapeutic microspheres. It improves the accuracy of SIRT work-up when compared to 99mTc-MAA, and aims to optimize patient selection and advance treatment planning.

Update: the uniklinikum Dresden have published their own (German) newsitem about the procedure, which you can find here.

Share this post

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Enable

Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.